6th International Conference on Progress in Alzheimer and Parkinson's Disease

 Seville, Spain, May 8-12, 2003

 

 


 

FOREWORD

This book consists of a collection of 27 papers written by selected authors, who had presented their research at the 6th. International Conference on Progress in Alzheimer’s and Parkinson’s Diseases (AD/PD 2003) that took place on May 8-12, 2003, in Seville Spain.

It serves as a companion piece to the Official Proceedings (OP) of the conference, which will be published later this year by the Martin Dunitz and Parthenon Publishing company.

Since there was a limit to the number of chapters that could be included in the OP, we restricted the contributions to chapters based on oral, invited presentations at the meeting. Monduzzi Editore has provided an avenue for the publication of selected additional chapters in the context of this book, thus expanding the scope of available information from the AD/PD 2003 proceedings.

In the interest of saving time and allowing rapid publication, we agreed with Monduzzi Editore’s request that, as editors, we would only correct major mistakes or errors in scientific logic and fact. We would not concern ourselves with differences in font type, style, or referencing in these chapters.

A more thorough and extensive editorial process will be employed with the OP manuscript.

We hope that this book will provide the reader with a modest overview of the scope and breadth of topics that were covered in the AD/PD 2003 conference. We also thank the authors for preparing their chapters at relatively short notice.

I. Hanin, Ph.D.
A. Fisher, Ph.D.
R. Cacabelos, M.D., Ph.D.

 


 

INDEX

 

Abnormal Cerebral MRIs In Mild Cognitive Impairment
J. Meyer1, A. El-Gengaihy, J. Thornby, M. Chowdhury, E. Maus, R. Fahmy and M. Quach

Cerebral Blood Flow Deficit on 123I-IMP SPECT in Advanced Parkinson’s Disease
H. Shibayama, K. Funakoshi, S. Sato, H. Nishino and T. Maki

PET Correlates of Cognitive Impairment in Lewy Body Disorders
C.S. Lee, B.L. Beattie, H. Feldman, V. Sossi, M.J. Adam, I.R. Mackenzie, A.J. Stoessl and T.J. Ruth.

Cognitive Impairment Risk and Protective Factors Prevalence in 2043 Individuals Over 65. Correlation with Memory Self-Evaluation and SPMSQ
R.L. Arizaga, R.F. Allegri, C.A. Mangone, J.A. Ollari, O. Genovese and C. Abel

Cerebrovascular Risk Factors and Brain Hemodynamics in Dementia
V. Pichel, I. Etcheverría, L. Amado, Y. Kubota and R. Cacabelos

Antibodies to AChE586-599 Distinguish Alzheimer’s Patients from Controls
J. Voskuil, M. Cottingham and D.J Vaux

Lipopolysaccharides Induce Inflammation-Mediated Neurodegeneration in the Substantia Nigra and Cerebral Cortex (A Case Report)
I. Niehaus

Effects of Leg Muscle Training on Parkinson’s Disease Patients
T. Kondo, R. Kodama, J. Kohmoto, I. Nakanishi, S. Morita,
Y. Hiwatani, H. Miwa and S. Maeshima

Partial Purification and Characterization of g-Secretase from Post Mortem Human Brain
M.R. Farmery, L.O. Tjernberg, S.E. Pursglove, A. Bergman, B. Winblad and J. Näslund

Calcium Dyshomeostasis in the Course of Disease in Individual Patients with Alzheimer´s Dementia
D. Øípová, V. Platilová and R. Jirák

Flow Cytometry Analysis of CD28-/CD8+ Suppressor Cell Precursor and CD45RO+/CD4+ Memory T Lymphocytes in the Peripheral Blood of Alzheimer’s Disease (AD) Patients
V.R.M. Lombardi, L. Amado, L. Fernández-Novoa, I. Etcheverría, S. Seoane and R. Cacabelos

Serum Nitric Oxide in Alzheimer Disease
L. Corzo, R. Zas, L. Fernández-Novoa and R. Cacabelos

Galantamine for Alzheimer´s Disease: A Novel Antiapoptotic Mechanism Linked to Overexpression of Bcl-2 and a7 Receptors
E. Arias, E. Ales, M.F. Cano-Abad, M. Villarroya, A.G. Garcia and M.G. Lopez

The Glucagon-like Peptides: New Therapeutic Strategy for Neurodegeneration
T.A. Perry, K. Sambamurti, D.K. Lahiri, M.P. Mattson, J.M. Egan and N.H. Greig

Mannan as a Molecular Adjuvant for Ab-Immunotherapy
D.H. Cribbs, A. Lees, A. Ghochikyan, V. Vasilevko, I. Petrushina, D. Babikyan, N. Movsesyan, M. Tran, A. DeVolger and M.G. Agadjanyan

Combination Therapy in Alzheimer Disease: A Pharmacogenomic Study
Y. Kubota, V. Pichel, L. Fernández-Novoa and R. Cacabelos

APOE Genotype-Related Brain Atrophy in the Spanish Population
I. Etcheverría, V. Pichel, L. Amado, L. Fernández-Novoa, V. Lombardi and R. Cacabelos

Park 8 – New Locus for an Autosomal Dominant Japanese Family
Hasegawa Kazuko, Funayama Manabu, Kowa Hisayuki, Tsuji Shoji and Obata Fumiya

Identification and Analysis of PACRG, a Novel Gene Linked to Parkin Via a Bi-directional Promoter
P.J. Lockhart, A.B. West, C. O’Farrell, M. de Lucia, D.W. Dickson and M.J. Farrer

Molecular Genetic Analysis of DRD2 and MAOB Loci in Patients with Parkinson’s Disease Treated with Dopamine Agonists and/or Specific MAO-B Inhibitor
M. Watanabe, S. Nissato, N. Ohkoshi, T. Yoshizawa, K. Yoshizawa, A. Hayashi and S. Shoji

Association Study Between Polymorphisms in the Promoter Region of the Alpha-synuclein Gene and Alzheimer’s Disease
H. Ujike, N. Uchida, A. Sakai, H. Kobayashi, J. Hasegawa, M. Yamamoto, Y. Fujisawa, Kanzaki, I. Kohira, M. Nakashima, Y. Takehisa, I. Sora and S. Kuroda.

The ACE Gene in Alzheimer’s Disease
L. Fernandez-Novoa, V.R.M. Lombardi, S. Seoane, I. Etcheverria, L. Corzo and R. Cacabelos

BACE Protein Expression Is Stimulated by IFN-g
H.S. Hong and I. Mook-Jung

Anti-Ab Polyclonal Sera from Wildtype Mice Recognized Predominantly EFRH Epitope
G. Gevorkian, I. Petrushina, A. Ghochikyan, K.G. Manoutcharian, G. Acero,
D.H. Cribbs and M.G. Agadjanyan

Neprilysin Mediated Prevention of Amyloid Plaque Formation
M.H. Mohajeri, R. Poirier, H. Li, M.A. Wollmer and R.M. Nitsch

Effects of ZSET845 and ZSET1446 on Acetylcholine Release in the Cortex and Learning Impairments in the Rat
Y. Yamaguchi, M. Takano, K. Saitoh, T. Matsuno and S. Kawashima

Cognitive-enhancing Properties of Galantamine Analogues in Rats and Mice
A. Gower, C. Williams, M. Smith and K. Czollner

 Via Maserati 5 Bologna Italy   - Tel. +39 051 4151123   Fax +39 051 370529